PCL (XKRX:241820) Common Stock : ₩27,019 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is PCL Common Stock?

PCL's quarterly common stock stayed the same from Sep. 2023 (₩25,764 Mil) to Dec. 2023 (₩25,764 Mil) but then increased from Dec. 2023 (₩25,764 Mil) to Mar. 2024 (₩27,019 Mil).

PCL's annual common stock increased from Dec. 2021 (₩5,185 Mil) to Dec. 2022 (₩5,979 Mil) and increased from Dec. 2022 (₩5,979 Mil) to Dec. 2023 (₩25,764 Mil).

PCL Common Stock Historical Data

The historical data trend for PCL's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCL Common Stock Chart

PCL Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

4,764.25

5,039.45

5,184.70

5,978.62

25,764.35

PCL Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															5,978.62	5,988.12	25,764.35	25,764.35	27,019.06

PCL Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

PCL (XKRX:241820) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PCL Inc (XKRX:241820) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Star Valley No. 701, 99, Digitalro, 9gi, Geumcheongu, Seoul, KOR, 08510

Website

http://www.pclchip.com

PCL Inc is engaged in the development of vitro diagnostics products by SG Cap technology used in immobilizing disease biomarkers. It offers blood testing kit, multiplex antigen detection kits, and ultra-low volume non-contact liquid handling.In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified.

PCL (XKRX:241820) Headlines

No Headlines